Patrick McEnany, CEO of Catalyst Pharmaceuticals, bought 25,000 shares of Catalyst Pharmaceuticals (Stock Symbol: CPRX) at $1.82 per share for a total amount of $45.5 thousand on February 7, 2014. Continue reading CEO Patrick McEnany, Catalyst Pharmaceuticals Insider, bought $45.5 thousand of shares on February 7, 2014